Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017 (2017), Article ID 4164130, 9 pages
https://doi.org/10.1155/2017/4164130
Research Article

Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

1Department of Radiology, University of Perugia, Perugia, Italy
2Department of General and Emergency Surgery, University of Perugia, Perugia, Italy
3Department of Medical Oncology, University of Perugia, Perugia, Italy
4Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy
5Department of Interventional Radiology, University La Sapienza, Rome, Italy

Correspondence should be addressed to E. Marino; moc.liamg@6891oniram.attebasile

Received 3 April 2017; Revised 13 June 2017; Accepted 6 July 2017; Published 15 August 2017

Academic Editor: Niccola Funel

Copyright © 2017 A. Rebonato et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferley, H. R. Shin, and F. Bray, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Llonej and J. Bruix, “Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival,” Hepatology, vol. 37, pp. 429–442, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Ietomi, “A study on the role of granulocytes in carcinoma- bearing hosts—G/L ratio as a new host indicator,” Nippon Gan Chiryo Gakkai Shi, vol. 25, pp. 662–671, 1990. View at Google Scholar
  4. A. Satomi, S. Murakami, K. Ishida, M. Mastuki, T. Hashimoto, and M. Sonoda, “Significance of increased neutrophils in patients with advanced colorectal cancer,” Acta Oncologica, vol. 34, pp. 69–73, 1995. View at Google Scholar
  5. S. R. Walsh, E. J. Cook, F. Goulder, T. A. Justin, and N. J. Keeling, “Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer,” Journal of Surgical Oncology, vol. 91, pp. 181–184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. K. M. Sarraf, E. Belcher, E. Raevsky, A. G. Nicholson, P. Goldstraw, and E. Lim, “Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, pp. 425–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. K. J. Halazun, A. Aldoori, H. Z. Malik et al., “Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases,” European Journal of Surgical Oncology, vol. 34, pp. 55–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Gomez, S. Farid, H. Z. Malik et al., “Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma,” World Journal of Surgery, vol. 32, pp. 1757–1762, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Graziosi, E. Marino, V. De Angelis, A. Rebonato, E. Cavazzoni, and A. Donini, “Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer,” American Journal of Surgery, vol. 209, no. 2, pp. 333–337, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Maltoni, A. Caraceni, C. Brunelli et al., “Prognostic factors in advanced cancer patients: evidence-based clinical recommendations – a study by the Steering Committee of the European Association for Palliative Care,” Journal of Clinical Oncology, vol. 23, no. 25, pp. 6240–6248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. C. S. Wang and C. F. Sun, “C-reactive protein and malignancy: clinico-pathological association and therapeutic implication,” Chang Gung Medical Journal, vol. 32, pp. 471–482, 2009. View at Google Scholar
  12. H. Y. Shau and A. Kim, “Suppression of lymphokine-activated killer induction by neutrophils,” Journal of Immunology, vol. 141, pp. 4395–4402, 1988. View at Google Scholar
  13. H. Jin, J. Sun, K. Zhu et al., “The prognostic value of neutrophil-lymphocyte ratio is superior to derived neutrophil-lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up,” OncoTargets and Therapy, vol. 10, pp. 2655–2664, 2017. View at Publisher · View at Google Scholar
  14. Y. Zhang, C. Ma, M. Wang et al., “Prognostic significance of immune cells in the tumor microenvironment and peripheral blood of gallbladder carcinoma patients,” Clinical & Translational Oncology, vol. 19, no. 4, pp. 477–488, 2017. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Arai, T. Fukumoto, M. Kido et al., “Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysis,” Surgery Today, vol. 47, no. 3, pp. 385–392, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Liao, Z. W. Tang, D. W. Li, S. Q. Luo, P. Huang, and C. Y. Du, “Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report,” World Journal of Surgical Oncology, vol. 13, p. 265, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. M. E. McNally, A. Martinez, H. Khabiri et al., “Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization,” Annals of Surgical Oncology, vol. 20, pp. 923–928, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Xu, W. Chen, L. Zhang et al., “Prognostic significance of neutrophil to lymphocyte ratio in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization,” Chinese Medical Journal, vol. 127, no. 24, pp. 4204–4209, 2014. View at Google Scholar
  19. R. Lencioni and J. M. Llovet, “Modified RECIST (mRECIST) assessment for hepatocellular carcinoma,” Seminars in Liver Disease, vol. 30, no. 1, pp. 52–60, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Balkwill and A. Mantovani, “Inflammation and cancer: back to Virchow,” Lancet, vol. 357, pp. 539–534, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. D. S. Wang, C. Ren, M. Z. Qiu et al., “Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer,” Tumour Biology, vol. 33, pp. 749–756, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Bhatti, O. Peacock, G. Lloyd, M. Larvin, and R. I. Hall, “Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio,” American Journal of Surgery, vol. 200, pp. 197–203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Wada, O. Nakashima, R. Kutami, O. Yamamoto, and M. Kojiro, “Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration,” Hepatology, vol. 27, pp. 407–414, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. P. E. Neagoe, A. Brkovic, F. Hajjar, and M. G. Sirois, “Expression and release of angiopoietin-1 from human neutrophils: intracellular mechanisms,” Growth Factors, vol. 27, pp. 335–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Asher, J. Lee, A. Innamaa, and A. Bali, “Preoperative platelet lymphocyte ratio as an in- dependent prognostic marker in ovarian cancer,” Clinical & Translational Oncology, vol. 13, pp. 499–503, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. G. P. Tuszynski and R. F. Nicosia, “The role of thrombospondin-1 in tumor progression and angiogenesis,” BioEssays, vol. 18, pp. 71–76, 1996. View at Publisher · View at Google Scholar
  27. W. K. Xiao, D. Chen, S. Q. Li, F. SJ, B. G. Peng, and L. J. Liang, “Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis,” BMC Cancer, vol. 14, p. 117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Fan, Y. Zhang, Y. Wang, X. Yao, J. Yang, and J. Li, “Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization,” PLoS One, vol. 10, no. 3, article e0119312, 2015. View at Publisher · View at Google Scholar · View at Scopus